Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Re: Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

Masuda S, Izpisua Belmonte JC.

J Natl Cancer Inst. 2014 Mar;106(3):djt457. doi: 10.1093/jnci/djt457. No abstract available.

2.

MicroRNA-21 in colorectal cancer: "Just another brick in the wall"?

Stintzing S, Lenz HJ.

J Natl Cancer Inst. 2013 Jun 19;105(12):840-1. doi: 10.1093/jnci/djt128. No abstract available.

3.

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

J Natl Cancer Inst. 2013 Jun 19;105(12):849-59. doi: 10.1093/jnci/djt101.

4.

Response.

Toiyama Y, Boland CR, Goel A.

J Natl Cancer Inst. 2014 Mar;106(3):djt458. doi: 10.1093/jnci/djt458. No abstract available.

5.

Diagnostic and prognostic significance of serum microRNAs in colorectal cancer.

Menéndez P, Villarejo P, Padilla D, Menéndez JM, Montes JA.

J Surg Oncol. 2013 Feb;107(2):217-20. doi: 10.1002/jso.23245. Review.

PMID:
22903548
6.

MicroRNA dysregulation in colorectal cancer: a clinical perspective.

Dong Y, Wu WK, Wu CW, Sung JJ, Yu J, Ng SS.

Br J Cancer. 2011 Mar 15;104(6):893-8. doi: 10.1038/bjc.2011.57. Review.

7.

Plasma microRNAs: a potential biomarker for colorectal cancer?

Schetter AJ, Harris CC.

Gut. 2009 Oct;58(10):1318-9. doi: 10.1136/gut.2009.176875. No abstract available.

PMID:
19749133
8.

Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.

Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, Ling S, Jiang L, Tian Y, Lin TY.

J Gastroenterol Hepatol. 2010 Oct;25(10):1674-80. doi: 10.1111/j.1440-1746.2010.06417.x.

PMID:
20880178
9.

Circulating miR-34a levels are reduced in colorectal cancer.

Nugent M, Miller N, Kerin MJ.

J Surg Oncol. 2012 Dec;106(8):947-52. doi: 10.1002/jso.23174.

PMID:
22648208
10.

Plasma miR-21: a potential diagnostic marker of colorectal cancer.

Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J, Galandiuk S.

Ann Surg. 2012 Sep;256(3):544-51. doi: 10.1097/SLA.0b013e318265bd6f.

PMID:
22868372
11.

Prognostic implications of serum microRNA-21 in colorectal cancer.

Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.

J Surg Oncol. 2013 Nov;108(6):369-73. doi: 10.1002/jso.23415.

PMID:
23970420
12.

Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.

Wang LG, Gu J.

Cancer Epidemiol. 2012 Feb;36(1):e61-7. doi: 10.1016/j.canep.2011.05.002.

PMID:
22018950
13.

Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.

Yu H, Gao G, Jiang L, Guo L, Lin M, Jiao X, Jia W, Huang J.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2904-11.

14.

Systemic microRNAs: novel biomarkers for colorectal and other cancers?

Heneghan HM, Miller N, Kerin MJ.

Gut. 2010 Jul;59(7):1002-4; author reply 1004. doi: 10.1136/gut.2009.200121. No abstract available.

PMID:
20581247
15.

Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.

Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W, Du X.

PLoS One. 2012;7(9):e44398. doi: 10.1371/journal.pone.0044398.

16.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475.

PMID:
23673725
17.

Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.

Luo X, Stock C, Burwinkel B, Brenner H.

PLoS One. 2013 May 14;8(5):e62880. doi: 10.1371/journal.pone.0062880.

18.

Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.

Le HB, Zhu WY, Chen DD, He JY, Huang YY, Liu XG, Zhang YK.

Med Oncol. 2012 Dec;29(5):3190-7. doi: 10.1007/s12032-012-0303-z.

PMID:
22782668
19.

Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.

Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao H, Sun Q, Yan F, Yan C, Li H, Ren X.

Gene. 2014 Jan 1;533(1):389-97. doi: 10.1016/j.gene.2013.09.038. Review.

PMID:
24076132
20.

Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer.

Faltejskova P, Bocanek O, Sachlova M, Svoboda M, Kiss I, Vyzula R, Slaby O.

Cancer Biomark. 2012;12(4):199-204. doi: 10.3233/CBM-130308.

PMID:
23568010
Items per page

Supplemental Content

Support Center